AzTrials
AzTrials

ShockRVPA-FLICUNCT07537621

Right Ventriculo-Arterial Coupling During Fluid Loading in ICU Patients

An observational study of Shock and Right Ventricular Dysfunction, run by CHU de Reims at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Preload responsiveness and venous congestion have largely been investigated independently in recent literature. However, recent data report a similar incidence of venous congestion regardless of fluid responsiveness status, challenging the concept of a linear continuum between preload independence and fluid… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Echography
How many people
100 participants
Where
1 siteFrance
Study dates
3 Jun 2026to 4 Jun 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of adult critically ill patients with acute circulatory failure. Eligible patients are those for whom the attending physician independently decides to perform fluid loading as part of standard care, in accordance with current European recommendations. Patients may present with hypotension requiring vasopressor support, low mean arterial pressure, or other signs of hemodynamic instability. Participants are prospectively and consecutively included at the time of fluid loading decision, and undergo standardized echocardiographic assessment of right ventricular function and venous congestion before and after fluid administration. The population reflects routine clinical practice in the intensive care unit.

Who may be able to join

  • Critically ill hospitalized patients
  • Age ≥ 18 years
  • Patients undergoing fluid loading at the discretion of the attending physician, following prediction of fluid responsiveness using any recommended maneuver or dynamic parameter, in the setting of acute circulatory failure requiring vasopressor support and/or mean arterial pressure < 65 mmHg (or a decrease of ≥ 30 mmHg from baseline in patients with chronic hypertension), and/or other signs of hemodynamic instability (tachycardia, mottling, oliguria, hyperlactatemia)
  • Affiliated with a national health insurance system

Who cannot join

  • Formal refusal from the patient or legally representative after information
  • Patients transferred from another intensive care unit
  • Pregnant or postpartum patients
  • Acute respiratory distress (defined as respiratory rate ≥ 35 breaths/min and/or signs of increased work of breathing)
  • Ongoing acute coronary syndrome
  • Acute or pulmonale (defined by right ventricular dilation associated with paradoxical septal motion related to an abrupt increase in right ventricular afterload)
Show all 10Show fewer
  • Primary pulmonary arterial hypertension
  • Intra-abdominal hypertension (intravesical pressure > 15 mmHg)
  • Poor echogenicity precluding adequate echocardiographic assessment of the right ventricle
  • Severe valvular heart disease or early postoperative period following valvular surgery

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Guillaume THERY contact

gthery@chu-reims.fr

France1 site, 1 recruiting
  • Marie Muller

    Reims

    Morgan CAPLAN, 03 10 73 60 22 ext. 0033, mcaplan@chu-reims.fr

    Guillaume THERY, gthery@chu-reims.fr

    Recruiting

Other trials in France

About this study

Official title: Prospective Observational Study of Right Ventriculo-arterial Coupling Changes During Fluid Loading and Their Relationship With Congestion Parameters in Critically Ill Adults

Preload responsiveness and venous congestion have largely been investigated independently in recent literature. However, recent data report a similar incidence of venous congestion regardless of fluid responsiveness status, challenging the concept of a linear continuum between preload independence and fluid intolerance. These findings support the need for a more individualized hemodynamic management strategy that takes venous congestion risk into account.

The right ventricle plays a central role in this framework. Its function is to maintain an adequate venous return pressure gradient to ensure cardiac output while limiting upstream venous congestion, under strong dependence on its afterload. In physiological conditions, the right ventricle adapts to changes in afterload by increasing contractility to preserve right ventriculo-arterial coupling and optimize its performance.

Read more

In chronic cardiopulmonary diseases, right ventriculo-arterial uncoupling is a well-established prognostic factor, including the presence of occult uncoupling revealed by fluid loading. In critically ill patients, right ventricular systolic dysfunction associated with venous congestion-defining right heart failure-is strongly associated with increased mortality, as is right ventriculo-arterial uncoupling itself.

To support the concept of fluid tolerance, the investigators hypothesize that impairment of right ventriculo-arterial coupling may exist or occur during fluid loading in critically ill patients, independently of preload responsiveness, and may be associated with worsening upstream venous congestion.

Read the detailed description

This is a prospective observational study designed to evaluate right ventriculo-arterial coupling dynamics during fluid loading in critically ill patients with acute circulatory failure. The study aims to characterize alterations in coupling, their relationship with venous congestion, and the performance of different echocardiographic indices used to quantify right ventricular function and coupling.

Study Population:

Critically ill adult patient in intensive care unit who require fluid loading as part of routine clinical management, based on the attending physician's discretion. Eligible patients may present with hypotension requiring vasopressor support, low mean arterial pressure, or other signs of hemodynamic instability. Patients are prospectively and consecutively included, reflecting standard ICU practice.

Study Procedures:

Fluid loading is administered according to current clinical guidelines. Echocardiographic assessment of the right ventricle is performed immediately before and after fluid administration. The primary measure of RVPA is the TAPSE/TRV ratio. Additional echocardiographic parameters will be collected and other validated indices to define RVPA to allow comparisons across methods.

Secondary Analyses:

Secondary analyses will stratify patients based on fluid responsiveness, defined as a ≥10% increase in cardiac output after fluid loading, and on the presence of venous congestion assessed by VExUS score and portal vein pulsatility. Baseline hemodynamic and echocardiographic parameters will be analyzed to identify predictors of RVPA deterioration. The relationship between RVPA and upstream venous congestion, organ dysfunction, ICU length of stay, and mortality will also be explored. Reproducibility of right ventricule parameters measurements will be assessed by calculating intra- and inter-observer variability.

Technical Considerations:

Echocardiography will be performed by trained operators using standardized acquisition protocols.

Measurements will include TAPSE, tricuspid regurgitation velocity, tricuspid S-wave velocity, PASP, FAC, and IVC diameter.

Data will be recorded before fluid loading and immediately after completion of the fluid challenge, typically within 30 minutes.

Fluid responsiveness will be assessed according to standard dynamic parameters or maneuvers selected by the attending physician.

Patients with poor echogenicity, acute respiratory distress, ongoing myocardial infarction, acute cor pulmonale, or other exclusion criteria will not be included.

Rationale:

The right ventricle is a key determinant of venous return and cardiac output, and its function is highly dependent on afterload. RVPA reflects the efficiency of coupling between right ventricular contractility and pulmonary arterial load. Understanding RVAC dynamics during fluid loading may inform individualized fluid management strategies, potentially minimizing venous congestion and organ dysfunction. Comparing different echocardiographic indices allows evaluation of their relative performance and reliability in detecting RV uncoupling in critically ill patients.

Data Management and Analysis:

All echocardiographic and hemodynamic data will be collected prospectively and recorded in a secure database. Changes in RVAC before and after fluid loading will be analyzed descriptively and in association with fluid responsiveness and venous congestion parameters. Agreement between different RVAC indices will be assessed using correlation and Bland-Altman analyses. Predictive models may be developed to identify baseline factors associated with RVAC deterioration.

Ethical Considerations:

Fluid loading is part of routine clinical care. No experimental interventions are applied. All patients or their legally authorized representatives will provide informed consent in accordance with institutional and national regulations.

Being tested
Echography
Keywords
Right ventriculo-arterial coupling, Fluid loading, Venous congestion, VEXUS score, Critical care echocardiography
Medical subject headings
Shock, Ventricular Dysfunction, Right, Hyperemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EchographyOther

    Fluid loading administered according to standard clinical practice at the discretion of the treating physician. Echocardiographic assessment of right ventricular function and venous congestion is performed before and after fluid administration. No experimental treatment is applied.

Study groups in NCT07537621
Study groupRoleWhat they receive
Critically Ill Patients Receiving Fluid LoadingThe study group consists of adult critically ill patients admitted to the intensive care unit who undergo fluid loading as part of routine clinical care, at the discretion of the attending physician. All patients are prospectively and consecutively included in a single observational cohort. Echocardiographic assessment of right ventricular function, right ventriculo-arterial coupling, and venous congestion parameters is performed before and after fluid administration. The group will be analyzed as a whole, with secondary analyses stratifying patients according to fluid responsiveness or presence of venous congestion. This cohort reflects standard clinical practice in critically ill patients with acute circulatory failure.
Receives: Other: Echography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Right Ventriculo-Arterial Coupling Changes During Fluid Loading

    Echocardiographic assessment of right ventriculo-arterial coupling will be performed using the TAPSE/TRV ratio before and after fluid loading. The primary outcome is the change in TAPSE/TRV, reflecting alterations in right ventricular contractility and coupling with the pulmonary circulation in response to fluid administration. This outcome will be used to evaluate the prevalence and dynamics of RV uncoupling in critically ill patients.

    Measured: Before a fluid loading procedure (approximately 30 min)

  2. Right Ventriculo-Arterial Coupling Changes During Fluid Loading

    Echocardiographic assessment of right ventriculo-arterial coupling will be performed using the TAPSE/TRV ratio before and after fluid loading. The primary outcome is the change in TAPSE/TRV, reflecting alterations in right ventricular contractility and coupling with the pulmonary circulation in response to fluid administration. This outcome will be used to evaluate the prevalence and dynamics of RV uncoupling in critically ill patients.

    Measured: after a fluid loading procedure (approximately 30 min)

Secondary outcomes (11)
  1. Variation of Right Ventriculo-Arterial Coupling According to Fluid Responsiveness

    Changes in right ventriculo-arterial coupling (TAPSE/TRV ratio) will be compared between fluid responders (RV+) and non-responders (RV-) to assess the influence of fluid responsiveness on coupling dynamics.

    Measured: Before a single fluid loading episode

  2. Variation of Right Ventriculo-Arterial Coupling According to Fluid Responsiveness

    Changes in right ventriculo-arterial coupling (TAPSE/TRV ratio) will be compared between fluid responders (RV+) and non-responders (RV-) to assess the influence of fluid responsiveness on coupling dynamics.

    Measured: after a single fluid loading episode

  3. Association Between Right Ventriculo-Arterial Coupling and Venous Congestion

    The relationship between TAPSE/TRV ratio and upstream venous congestion parameters, including VExUS score and portal vein pulsatility, will be evaluated to determine the impact of right ventricular uncoupling on venous congestion.

    Measured: Before fluid loading

  4. Association Between Right Ventriculo-Arterial Coupling and Venous Congestion

    The relationship between TAPSE/TRV ratio and upstream venous congestion parameters, including VExUS score and portal vein pulsatility, will be evaluated to determine the impact of right ventricular uncoupling on venous congestion.

    Measured: after fluid loading

  5. Predictors of Right Ventriculo-Arterial Coupling Deterioration

    Baseline hemodynamic and echocardiographic parameters will be analyzed to identify predictors of subsequent deterioration in right ventriculo-arterial coupling during fluid loading.

    Measured: before fluid loading

  6. Comparison of Echocardiographic Parameters Across Groups

    Echocardiographic indices characterizing right ventricular function and coupling will be compared between fluid responders, non-responders, and patients with or without venous congestion to assess differences in right ventricular performance.

    Measured: before fluid loading

  7. Comparison of Echocardiographic Parameters Across Groups

    Echocardiographic indices characterizing right ventricular function and coupling will be compared between fluid responders, non-responders, and patients with or without venous congestion to assess differences in right ventricular performance.

    Measured: after fluid loading

  8. Comparison of Echocardiographic Parameters Characterizing Right Ventriculo-Arterial Coupling

    Different echocardiographic indices of right ventriculo-arterial coupling, including TAPSE/PASP ratio, tricuspid S-wave velocity/PASP ratio, and other validated measures, will be compared to assess their agreement and performance in detecting right ventricular uncoupling. Analyses will consider fluid responsiveness and presence of venous congestion.

    Measured: before fluid loading

  9. TAPSE/PASP Ratio as a Marker of Right Ventriculo-Arterial Coupling Coupling

    The TAPSE/PASP ratio will be measured by echocardiography to assess right ventriculo-arterial coupling. Its diagnostic performance in detecting right ventricular uncoupling will be evaluated, considering fluid responsiveness and the presence of venous congestion./PASP ratio, tricuspid S-wave velocity/PASP ratio, and other validated measures, will be compared to assess their agreement and performance in detecting right ventricular uncoupling. Analyses will consider fluid responsiveness and presence of venous congestion.

    Measured: after fluid loading

  10. Tricuspid S-wave Velocity/PASP Ratio as a Marker of Right Ventriculo-Arterial Coupling

    The tricuspid annular S-wave velocity/PASP ratio will be measured by echocardiography to assess right ventriculo-arterial coupling. Its diagnostic performance in detecting right ventricular uncoupling will be evaluated, considering fluid responsiveness and the presence of venous congestion.

    Measured: After fluid loading

  11. Agreement Between Echocardiographic Indices of Right Ventriculo-Arterial Coupling

    The level of agreement between the different validated echocardiographic indices of right ventriculo-arterial coupling (TAPSE/PASP ratio, tricuspid S-wave velocity/PASP ratio) will be assessed using Bland-Altman analysis and intraclass correlation coefficients. Analyses will account for fluid responsiveness and the presence of venous congestion.

    Measured: After fluid loading

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2026
  2. Study start3 Jun 2026
  3. Primary completion4 Jun 2029 (estimated)
  4. Study completion4 Jun 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07537621
Sponsor's protocol ID
PL26041
Acronym
RVPA-FLICU
Status last verified
Jun 2026
First submitted
8 Apr 2026
Last updated
10 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Shock and Right Ventricular Dysfunction, run by CHU de Reims at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Morgan CAPLAN (03 10 73 60 22 ext. 0033, mcaplan@chu-reims.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Right Ventriculo-Arterial Coupling Changes During Fluid Loading (time frame: Before a fluid loading procedure (approximately 30 min)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in